Trial Profile
Open-label prospective study investigating effect of bortezomib plus dexamethasone therapy on reduction in anti-HLA antibodies in renal transplantation patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics; Therapeutic Use
- 28 Dec 2015 New trial record